Physician
Oncology
Dr. Kemp B. Cease, MD
|
|
Give Review
Kemp B. Cease, MD practices Oncology. He studied medicine at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is a top medical university. University of North Carolina at Chapel Hill School of Medicine is ranked 22 in research and 2 in primary care medicine Kemp Cease has written publications. He has 16 publications published with PubMed. The lastest paper is: 'Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.'
Publications
- Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.
- Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
- In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
- Staphylococcus δ-toxin induces allergic skin disease by activating mast cells.
- A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung Cancer.
- Recombinant vaccine displaying the loop neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.
- Cancer CarePartners: Improving patients' symptom management by engaging informal caregivers.
- A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
- Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung Cancer treated with radiotherapy.
- A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillu...
- Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
- Time to treatment in patients with stage III non-small cell lung Cancer.
- The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung Cancer.
- Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors.
- Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.
Schools
University Of North Carolina Chapel Hill School Of Medicine
University Of Michigan
National Institute Of Health
Conditions Treated
- Bladder Cancer
- Breast Cancer
- Colorectal Cancer
- ENT Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
University of Michigan Hospitals and Health Centers -
University of North Carolina at Chapel Hill School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Rami N. Khoriaty, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory P. Kalemkerian, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Norah L. Henry, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Christine M. Veenstra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moshe Talpaz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sofia D. Merajver, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Stephen B. Gruber, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Anne F. Schott, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Muneesh Tewari, MD
This Doctor is OpenDoctor Recommended.
|